GlaxoSmithKline (GSK)

41.00 +0.78 (1.94%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (5/1/19 *Est.)

Latest Headlines

GlaxoSmithKline (GSK) launches the sale of two portfolios of Latam consumer health drugs and physiogel skincare drugs - Reuters June 19, 2019 1:26 PM - StreetInsider Morgan Stanley Reinstates GlaxoSmithKline (GSK:LN) (GSK) at Underweight June 17, 2019 7:34 AM - StreetInsider Form 6-K GLAXOSMITHKLINE PLC For: Jun 12 June 12, 2019 1:32 PM - SEC Filing Form 6-K GLAXOSMITHKLINE PLC For: Jun 07 June 7, 2019 6:38 AM - SEC Filing GlaxoSmithKline (GSK) Announces Nucala Gains FDA Approval for Two New Self-Administration Options June 6, 2019 5:15 PM - StreetInsider Nucala (mepolizumab) Gains FDA Approval for Two New Self-Administration Options June 6, 2019 5:15 PM - BizWire Form 6-K GLAXOSMITHKLINE PLC For: Jun 04 June 4, 2019 6:22 AM - SEC Filing Form 6-K GLAXOSMITHKLINE PLC For: Jun 03 June 3, 2019 11:11 AM - SEC Filing Matinas BioPharma to Present at the 9th Annual LD Micro Invitational June 3, 2019 8:05 AM - Globe NewsWire Form SD GLAXOSMITHKLINE PLC May 31, 2019 2:05 PM - SEC Filing Form 6-K GLAXOSMITHKLINE PLC For: May 24 May 24, 2019 6:27 AM - SEC Filing Form 6-K GLAXOSMITHKLINE PLC For: May 20 May 20, 2019 9:54 AM - SEC Filing Zymeworks (ZYME), GSK Expand 2016 Azymetric Bispecific Agreement May 16, 2019 6:46 AM - StreetInsider Thermo Fisher Scientific (TMO) Acquires Manufacturing Site in Cork, Ireland from GlaxoSmithKline (GSK) for EUR90M in Cash May 16, 2019 5:51 AM - StreetInsider Thermo Fisher Scientific to Acquire Manufacturing Site in Cork, Ireland, from GSK May 16, 2019 5:00 AM - PR NewsWire Matinas BioPharma Announces a Research Collaboration with ViiV Healthcare to Evaluate Formulation of Antiviral Drug Candidates May 15, 2019 7:00 AM - Globe NewsWire Form 6-K GLAXOSMITHKLINE PLC For: May 13 May 13, 2019 4:34 PM - SEC Filing Form 6-K GLAXOSMITHKLINE PLC For: May 13 May 13, 2019 4:06 PM - SEC Filing Form 6-K GLAXOSMITHKLINE PLC For: May 08 May 8, 2019 2:03 PM - SEC Filing GlaxoSmithKline (GSK:LN) (GSK) PT Raised to GBp1,550 at Deutsche Bank May 3, 2019 2:49 AM - StreetInsider Form CT ORDER GLAXOSMITHKLINE PLC May 2, 2019 4:19 PM - SEC Filing Form 6-K GLAXOSMITHKLINE PLC For: May 02 May 2, 2019 12:49 PM - SEC Filing Innoviva (INVA), GlaxoSmithKline (GSK) Phase III CAPTAIN Study of Trelegy Ellipta in Patients with Asthma Meets Primary Endpoint May 2, 2019 12:22 PM - StreetInsider Phase III CAPTAIN Study of Trelegy Ellipta in Patients with Asthma Meets Primary Endpoint May 2, 2019 12:18 PM - BizWire Barclays Reiterates Equalweight Rating on GlaxoSmithKline (GSK) May 2, 2019 1:25 AM - StreetInsider Form 6-K GLAXOSMITHKLINE PLC For: May 01 May 1, 2019 1:38 PM - SEC Filing Form 6-K GLAXOSMITHKLINE PLC For: May 01 May 1, 2019 1:19 PM - SEC Filing Form 6-K GLAXOSMITHKLINE PLC For: May 01 May 1, 2019 11:27 AM - SEC Filing GlaxoSmithKline (GSK) option implied volatility flat into EPS and outlook April 30, 2019 12:31 PM - StreetInsider Form 6-K GLAXOSMITHKLINE PLC For: Apr 29 April 29, 2019 8:28 AM - SEC Filing ViiV Healthcare Submits New Drug Application to US FDA for the First Monthly, Injectable, Two-Drug Regimen of Cabotegravir and Rilpivirine for Treatment of HIV April 29, 2019 7:06 AM - BizWire Form 6-K GLAXOSMITHKLINE PLC For: Apr 26 April 26, 2019 1:48 PM - SEC Filing Jefferies Reiterates Buy Rating on GlaxoSmithKline (GSK) April 23, 2019 2:16 AM - StreetInsider Form 6-K GLAXOSMITHKLINE PLC For: Apr 16 April 16, 2019 4:29 PM - SEC Filing Form 6-K GLAXOSMITHKLINE PLC For: Apr 16 April 16, 2019 3:08 PM - SEC Filing Form 6-K GLAXOSMITHKLINE PLC For: Apr 16 April 16, 2019 1:44 PM - SEC Filing Form 6-K GLAXOSMITHKLINE PLC For: Apr 16 April 16, 2019 1:39 PM - SEC Filing Form 6-K GLAXOSMITHKLINE PLC For: Apr 15 April 15, 2019 11:27 AM - SEC Filing Form 6-K GLAXOSMITHKLINE PLC For: Apr 12 April 12, 2019 1:30 PM - SEC Filing Form 6-K GLAXOSMITHKLINE PLC For: Apr 12 April 12, 2019 12:55 PM - SEC Filing Form 6-K GLAXOSMITHKLINE PLC For: Apr 11 April 11, 2019 2:03 PM - SEC Filing Barclays Reiterates Equalweight Rating on GlaxoSmithKline (GSK) April 10, 2019 3:21 AM - StreetInsider Form 6-K GLAXOSMITHKLINE PLC For: Apr 09 April 9, 2019 8:23 AM - SEC Filing GlaxoSmithKline (GSK) and Pfizer (PFE) announce FDA approval of ViiV Healthcare's Dovato for treatment-naïve HIV-1 adults April 8, 2019 4:54 PM - StreetInsider US FDA approves ViiV Healthcare’s Dovato (dolutegravir/lamivudine), the first, once-daily, single-tablet, two-drug regimen for treatment-naïve HIV-1 adults April 8, 2019 4:49 PM - BizWire FDA approves first two-drug complete regimen for HIV-infected patients who have never received antiretroviral treatment April 8, 2019 3:35 PM - StreetInsider Deutsche Bank Reiterates Hold Rating on GlaxoSmithKline (GSK) April 5, 2019 4:27 AM - StreetInsider UBS Reiterates Neutral Rating on GlaxoSmithKline (GSK) April 4, 2019 4:49 AM - StreetInsider GlaxoSmithKline (GSK) option implied volatility at low end of range April 3, 2019 11:05 AM - StreetInsider Form 6-K GLAXOSMITHKLINE PLC For: Apr 02 April 2, 2019 8:17 AM - SEC Filing Form 6-K GLAXOSMITHKLINE PLC For: Apr 02 April 2, 2019 8:12 AM - SEC Filing Form 6-K GLAXOSMITHKLINE PLC For: Apr 01 April 1, 2019 1:34 PM - SEC Filing SpringWorks Therapeutics Completes $125 Million Series B Financing April 1, 2019 6:30 AM - BizWire Form CERT GLAXOSMITHKLINE PLC March 29, 2019 9:03 AM - SEC Filing Form 6-K GLAXOSMITHKLINE PLC For: Mar 28 March 28, 2019 4:08 PM - SEC Filing Form 6-K GLAXOSMITHKLINE PLC For: Mar 25 March 25, 2019 2:24 PM - SEC Filing Form 8-A12B GLAXOSMITHKLINE PLC March 25, 2019 1:56 PM - SEC Filing Full Article List